Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia Prospective Study

European Journal of Endocrinology

Volumn 167, Issue 1, 2012, Pages 27-33

  Andersen, Mette K ^a,b   Lundgren, Virve ^a,b   Isomaa, Bo ^b,c   Groop, Leif ^a,d   Tuomi, Tiinamaija ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c Department of Social Services and Health Care ^*  (Finland)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INSULIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADULT; ARTICLE; CTLA4 GENE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HLA DQ2.5 GENE; HLA DQ8 GENE; HLA DQA1 GENE; HLA DQB1 GENE; HUMAN; INS GENE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTPN22 GENE; QUANTITATIVE TRAIT;

ALLELES; AUTOANTIBODIES; CTLA-4 ANTIGEN; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HUMANS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 84862746621     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0023     Document Type: Article

References (34)

1. Hampe CS, Hall TR, Agren A & Rolandsson O. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes. Clinical and Experimental Immunology 2007 148 72-78. (doi:10.1111/j.1365-2249.2007.03334.x)
2. Lundgren VM, Isomaa B, Lyssenko V, Laurila E, Korhonen P, Groop LC & Tuomi T & Botnia Study Group. GAD antibody positivity predicts type 2 diabetes in an adult population. Diabetes 2010 59 416-422. (doi:10.2337/db09- 0747)
3. Gottlieb MS. Diabetes in offspring and siblings of juvenile- and maturity-onset-type diabetics. Journal of Chronic Diseases 1980 33 331-339. (doi:10.1016/0021-9681(80)90042-9)
4. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A &Wall S. The Swedish childhood diabetes study - results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989 32 2-6. (doi:10.1007/BF00265396)
5. Li H, Isomaa B, Taskinen MR, Groop L & Tuomi T. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care 2000 23 589-594. (doi:10.2337/diacare.23.5.589)
6. Rafiq S, Melzer D, Weedon MN, Lango H, Saxena R, Scott LJ, DIAGRAM Consortium, Palmer CN, Morris AD, McCarthy MI, Ferrucci L, Hattersley AT, Zeggini E & Frayling TM. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia 2008 51 2205-2213. (doi:10.1007/s00125-008-1160-3)
7. Raj SM, Howson JM, Walker NM, Cooper JD, Smyth DJ, Field SF, Stevens HE & Todd JA. No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 2009 52 2109-2116. (doi:10.1007/s00125-009-1391-y)
8. Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, Takeuchi F, Wu Y, Go MJ, Yamauchi T, Chang YC, Kwak SH, Ma RC, Yamamoto K, Adair LS, Aung T, Cai Q, Chang LC, Chen YT, Gao Y, Hu FB, Kim HL, Kim S, Kim YJ, Lee JJ, Lee NR, Li Y, Liu JJ, Lu W, Nakamura J, Nakashima E, Ng DP, Tay WT, Tsai FJ, Wong TY, Yokota M, Zheng W, Zhang R, Wang C, So WY, Ohnaka K, Ikegami H, Hara K, Cho YM, Cho NH, Chang TJ, Bao Y, Hedman AK, Morris AP, McCarthy MI, DIAGRAM Consortium, MuTHER Consortium, Takayanagi R, Park KS, Jia W, Chuang LM, Chan JC, Maeda S, Kadowaki T, Lee JY, Wu JY, Teo YY, Tai ES, Shu XO, Mohlke KL, Kato N, Han BG & Seielstad M. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nature Genetics 2011 44 67-72. (doi:10.1038/ng.1019)
9. Billings LK & Florez JC. The genetics of type 2 diabetes: what have we learned from GWAS? Annals of the New York Academy of Sciences 2010 1212 59-77. (doi:10.1111/j.1749-6632.2010.05838.x)
10. Lethagen AL, Ericsson UB, Hallengren B, Groop L & Tuomi T. Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis. Journal of Clinical Endocrinology and Metabolism 2002 87 1177-1183. (doi:10.1210/jc.87.3.1177)
11. Niskanen LK, Tuomi T, Karjalainen J, Groop LC & Uusitupa MI. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995 18 1557-1565. (doi:10.2337/diacare.18.12.1557)
12. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF & Holman R. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997 350 1288-1293. (doi:10.1016/S0140-6736(97)03062-6)
13. Borg H, Gottsater A, Landin-Olsson M, Fernlund P & Sundkvist G. High levels of antigen-specific islet antibodies predict future b-cell failure in patients with onset of diabetes in adult age. Journal of Clinical Endocrinology and Metabolism 2001 86 3032-3038. (doi:10.1210/jc.86.7.3032)
14. Howson JM, Stevens H, Smyth DJ, Walker NM, Chandler KA, Bingley PJ & Todd JA. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011 60 2635-2644. (doi:10.2337/db11-0131)
15. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, Stevens H, Jackson L, Simmonds MJ, Type 1 Diabetes Genetics Consortium, Bingley PJ, Gough SC & Todd JA. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genetics 2011 7 e1002216. (doi:10.1371/journal.pgen.1002216)
16. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B & Taskinen MR. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996 45 1585-1593. (doi:10.2337/ diabetes.45.11.1585)
17. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L & Tuomi T & Botnia study group. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005 54 166-174. (doi:10.2337/diabetes.54.1.166)
18. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470. (doi:10.2337/diacare.22.9.1462)
19. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH & Knowler WC. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. American Journal of Epidemiology 2000 151 190-198. (doi:10.1093/ oxfordjournals.aje.a010187)
20. Monsuur AJ, de Bakker PI, Zhernakova A, Pinto D, Verduijn W, Romanos J, Auricchio R, Lopez A, van Heel DA, Crusius JB & Wijmenga C. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 2008 3 e2270 (Doi:10.1371/journal. pone.0002270). (doi:10.1371/journal.pone.0002270)
21. Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG & Gorus FK. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 1997 20 1547-1552. (doi:10.2337/diacare.20.10.1547)
22. Kulmala P, Rahko J, Savola K, Vahasalo P, Sjoroos M, Reunanen A, Ilonen J & Knip M. β-Cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren. Diabetes Care 2001 24 171-173. (doi:10.2337/diacare.24.1.171-a)
23. Gullstrand C, Wahlberg J, Ilonen J, Vaarala O & Ludvigsson J. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study. Pediatric Diabetes 2008 9 182-190. (doi:10.1111/j.1399-5448.2008.00369.x)
24. Sanjeevi CB, Falorni A, Kockum I, Hagopian WA & Lernmark A. HLA and glutamic acid decarboxylase in human insulindependent diabetes mellitus. Diabetic Medicine 1996 13 209-217. (doi:10.1002/(SICI)1096-9136(199603)13: 3<209::AID-DIA39>3.0.CO;2-2)
25. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J & Lernmark A. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. Journal of Clinical Investigation 1995 95 1505-1511. (doi:10.1172/JCI117822)
26. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G & Blohme G. Diabetes Incidence in Sweden Study Group. Swedish Childhood Diabetes Study Group. Genetic effects on agedependent onset and islet cell autoantibodymarkers intype1diabetes. Diabetes 2002 51 1346-1355. (doi:10.2337/diabetes.51.5.1346)
27. Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, Pociot F, Caillat-Zucman S, Timsit J & Julier C. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 2007 56 522-526. (doi:10.2337/db06-0942)
28. Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T & Ilonen J. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in Berlin, Germany. Experimental and Clinical Endocrinology & Diabetes 2010 118 245-249. (doi:10.1055/s-0029-1246213)
29. Andersen MK, Lundgren V, Turunen JA, Forsblom C, Isomaa B, Groop PH, Groop L & Tuomi T. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 2010 33 2062-2064. (doi:10.2337/dc09-2188)
30. Rajasalu T, Haller K, Salur L, Kisand K, Tillmann V, Schlosser M & Uibo R. Insulin VNTRI/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. Diabetes/Metabolism Research and Reviews 2007 23 567-571. (doi:10.1002/dmrr.745)
31. Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lahde J, Simell O, Knip M & Ilonen J. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral b cell autoimmunity. Diabetologia 2005 48 1766-1775. (doi:10.1007/s00125-005-1844-x)
32. Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G & Gorus FK. CTLA-4 gene polymorphism confers susceptibility to insulindependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clinical and Experimental Immunology 1997 110 98-103. (doi:10.1111/j.1365-2249.1997.t01-1-512-ce1410.x)
33. Manolio TA, Bailey-Wilson JE & Collins FS. Genes, environment and the value of prospective cohort studies. Nature Reviews. Genetics 2006 7 812-820. (doi:10.1038/nrg1919)
34. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P & Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. New England Journal of Medicine 2008 359 2220-2232. (doi:10.1056/NEJMoa0801869)